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Although CSFD is often used as a protective adjunct
against spinal cord ischemia, its benefit remains unproven.
Several retrospective studies suggest a benefit but are dif-
ficult to interpret because of confounding factors.11,15-17
Previous randomized clinical trials have reported conflict-
ing results.13,18 The purpose of this study was to evaluate
the impact of CSFD on the incidence of spinal cord injury
after extensive TAAA repair.
METHODS
Study design. The protocol was approved by Baylor
College of Medicine’s Institutional Review Board. After a
randomization sequence was generated with a computer,
assignments (repair with or without CSFD) were placed
into sequentially numbered opaque envelopes. Only
patients who underwent planned repair of extensive
TAAAs (Crawford extent I or II19) were eligible.
Preoperative exclusion criteria included previous TAAA
surgery, shock, and contraindications to spinal catheter
placement. A sealed randomization envelope was opened
immediately before operation in patients without preoper-
ative exclusion criteria. The surgical team was not blinded
to group assignment. All randomized patients were fol-
lowed in accordance with intention-to-treat principles.
Ischemic spinal cord injury after thoracoabdominal
aortic aneurysm (TAAA) repair remains a devastating
complication. In addition to the inherent physical disabil-
ity, patients with postoperative paraplegia and paraparesis
have decreased survival rates.1 Neurologic outcome is
influenced by aneurysm extent, acute dissection, increas-
ing cross-clamp times, preoperative renal dysfunction, pre-
vious aortic surgery, diabetes, and rupture.1-6 The variety
of adjuncts currently used, which include generalized7 and
local hypothermia,8 medications such as steroids,9 nalox-
one hydrochloride,10,11 barbiturates,12 and papaverine
hydrochloride,13 reattachment of intercostal arteries,14
and cerebrospinal fluid drainage (CSFD),15,16 is testimony
to the fact that no method has been universally effective in
prevention of paraplegia.
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CLINICAL RESEARCH STUDIES
Cerebrospinal fluid drainage reduces paraplegia
after thoracoabdominal aortic aneurysm repair:
Results of a randomized clinical trial
Joseph S. Coselli, MD, Scott A. LeMaire, MD, Cüneyt Köksoy, MD, Zachary C. Schmittling, MD, and
Patrick E. Curling, MD, Houston, Tex
Objective: Despite the use of various strategies for the prevention of spinal cord ischemia, paraplegia and paraparesis
continue to occur after thoracoabdominal aortic aneurysm (TAAA) repair. Although cerebrospinal fluid drainage
(CSFD) is often used as an adjunct for spinal cord protection, its benefit remains unproven. The purpose of this ran-
domized clinical trial was to evaluate the impact of CSFD on the incidence of spinal cord injury after extensive TAAA
repair.
Methods: After randomization, 145 patients underwent extent I or II TAAA repairs with a consistent strategy of moder-
ate heparinization, permissive mild hypothermia, left heart bypass, and reattachment of patent critical intercostal arter-
ies. The repairs were performed with CSFD (n = 76) or without CSFD (n = 69). In the former group, CSFD was
initiated during the operation and continued for 48 hours after surgery. The target CSF pressure was 10 mm Hg or less.
Results: The two groups had similar risk factors for paraplegia. Aortic clamp time, left heart bypass time, and number
of reattached intercostal arteries were also similar in both groups. Thirty-day mortality rates were 5.3% (four patients)
and 2.9% (two patients) for CSFD and control groups, respectively (P = .68). Nine patients (13.0%) in the control
group had paraplegia or paraparesis develop. In contrast, only two patients in the CSFD group (2.6%) had deficits
develop (P = .03). No patients with CSFD had immediate paraplegia. Overall, CSFD resulted in an 80% reduction in
the relative risk of postoperative deficits.
Conclusion: Perioperative CSFD reduces the rate of paraplegia after repair of extent I and II TAAAs. (J Vasc Surg
2002;35;631-9.)
For the study to be focused on a single treatment variable
(CSFD) in patients who underwent extensive TAAA
repairs, the following two secondary intraoperative exclu-
sion criteria were defined a priori: 1, inability to use left
heart bypass (LHB); and 2, performance of a less extensive
repair (extent III or IV) than planned. The study end-
points were death, paraplegia, and paraparesis.
Patients. The planned total enrollment was 184
patients. Between May 29, 1997, and April 1, 1999, 308
patients underwent TAAA repair. Of these, 202 consecu-
tive patients (65.6%) were eligible on the basis of a
planned extent I or II TAAA repair (Fig 1). Forty-six
patients (22.8%) were not randomized because of previous
TAAA operation, preoperative shock, patient decision
against participation, contraindications to spinal catheter
placement (coagulopathy, prior back surgery, etc), or
logistic issues. Ultimately, 156 patients (77.2%) met the
study criteria and were randomized after written informed
consent was obtained: 74 patients (47.4%) were random-
ized to the control group and 82 patients (52.6%) were
randomized to CSFD. Interim analysis results after the
enrollment of 156 patients showed significant differences,
and therefore the study was halted. 
Operative technique. All patients underwent graft
repair with standardized techniques and a consistent strat-
egy for spinal cord protection: LHB, moderate hepariniza-
tion, permissive mild hypothermia, and aggressive
reattachment of available critical intercostal and lumbar
arteries (thoracic vertebrae 7 [T7] to lumbar vertebrae 2
[L2]).20-22 The experimental group underwent CSFD in
addition to these adjuncts.
The aorta was exposed with a left thoracoabdominal
incision and circumferential division of the diaphragm.
After moderate systemic heparinization (1 mg/kg), LHB
was established with cannulae inserted into the left inferior
pulmonary vein and the distal descending thoracic aorta;
the bypass circuit did not include an oxygenator or heat
exchanger. Nasopharyngeal temperature was allowed to
drift to 32°C to 33°C. Depending on the proximal extent
of the aneurysm, an aortic clamp was placed either proxi-
mal or distal to the left subclavian artery. After placement
of a second aortic cross-clamp between T4 and T7, the
segment of aorta between the clamps was opened. Patent
intercostal arteries within this proximal segment were
oversewn. After completion of the proximal anastomosis,
LHB was discontinued, the distal clamp was removed, and
the remaining aneurysm was opened longitudinally. In
patients who underwent extent II repairs, balloon perfu-
sion catheters were positioned within the origins of the
celiac, superior mesenteric, and renal arteries for selective
visceral perfusion delivered from the LHB circuit.
Whenever possible, patent segmental arteries between T7
and L2 were reattached to the graft. The visceral and renal
arteries were reattached with either a beveled open distal
anastomosis (extent I) or inclusion patch (extent II). After
reattachment of the visceral and renal vessels in extent II
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Fig 1. Diagram shows trial profile, including participant flow after randomization, patient availability for intention-to-treat
analysis, and withdrawals for secondary efficacy analysis. TAAA, Thoracoabdominal aortic aneurysm; CSFD, cerebrospinal
fluid drainage; LHB, left heart bypass; DTA, descending thoracic aortic aneurysm.
repairs, the balloon catheters were removed; whenever
possible, the clamp was replaced below the renal arteries
to provide intercostal and visceral/renal perfusion during
the open distal aortic anastomosis. Hypotension after
cross-clamp removal was avoided with vigorous volume
replacement and, when necessary, intravenous inotropes
or pressors. The operative field was irrigated with warm
saline solution after completion of all anastomoses. No
other means of rewarming the patient were used during
the operation. Warm air blankets (Bair Hugger, Augustine
Medical, Inc, Eden Prairie, Minn) were used after surgery. 
Cerebrospinal fluid drainage. Patients randomized to
undergo CSFD were placed in right lateral decubitus posi-
tion, and a 5F silicone lumbar catheter (Elekta Instruments,
Inc, Atlanta, Ga) was introduced into the subarachnoid
space at the L3 or L4 intervertebral space via a Tuohy nee-
dle. The catheter was connected to a pressure transducer
and a drainage set that included a 75-mL graduated cylin-
der and a 500-mL drainage bag (Elekta Instruments, Inc).
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 4 Coselli et al 633
The transducer’s zero point was set while level with the
patient’s spine. The CSF pressure was monitored continu-
ously during surgery and the early postoperative period.
Cerebrospinal fluid was allowed to freely drain with gravity
whenever CSF pressure exceeded 10 mm Hg. In patients
without a spinal cord deficit, the drain was removed on
postoperative day 2. In the presence of neurologic injury,
however, the catheter was kept in place beyond 2 days. 
Neurologic evaluation. Each patient’s neurologic
status was evaluated daily until discharge and was classified
as “deficit” or “no deficit.” Lower extremity motor func-
tion was assessed by either asking the patient to alternately
raise each leg off of the bed (early after operation) or
observing ambulation (later). Deficits were scored as
described by Crawford et al18: 1, minimal or no motion;
2, motion but not against resistance or gravity; 3, motion
against resistance and gravity but no ability to stand or
walk; and 4, ability to stand and walk with assistance.
Deficit scores during the initial postoperative course were
Table I. Comparison of preoperative characteristics for patients who underwent thoracoabdominal aortic aneurysm
repair with and without cerebrospinal fluid drainage
Variable CSFD ( n = 76) Control (n = 69) P value
Age (years) 65.5 ± 10.2 65.5 ± 10.9 .99
Male/female 46/30 44/25 .73
Hypertension 62 (81.6%) 54 (78.3%) .68
Chronic obstructive pulmonary disease* 12 (15.8%) 16 (23.2%) .30
Renal failure† 4 (5.3%) 4 (5.8%) 1.0
Diabetes mellitus 3 (3.9%) 3 (4.3%) 1.0
Marfan syndrome 4 (5.3%) 5 (7.2%) .74
FEV1 (% of predicted) 73.6 ± 19.2 68.9 ± 18.1 .23
Left ventricular ejection fraction 60.0% ± 11.2% 59.4% ± 12.8% .80
Active smoker 47 (61.8%) 45 (65.2%) .73
Preoperative creatinine level
<1.5 mg/dL 58 (78.4%) 58 (84.1%) .40
1.5 to 2.0 mg/dL 11 (14.9%) 8 (11.6%) .63
>2 mg/dL 5 (6.8%) 3 (4.3%) .72
Cause of aneurysm
MDD 46 (60.5%) 39 (56.5%) .74
Chronic dissection 25 (32.9%) 25 (36.2%) .73
Acute dissection 4 (5.3%) 1 (1.4%) .40
MDD + superimposed acute dissection 0 1 (1.4%) .48
MDD + superimposed chronic dissection 1 (1.3%) 3 (4.3%) .35
Symptoms
No symptoms 16 (23.5%) 23 (35.4%) .18
Mild symptoms 36 (52.9%) 35 (53.8%) 1.0
Severe pain 16 (23.5%) 7 (10.8%) .07
Acute presentation‡ 6 (7.9%) 4 (5.8%) .75
Aneurysm extent
I 32 (42.1%) 33 (47.8%) .51
II 44 (57.9%) 36 (52.2%) .51
Previous aortic surgery
Ascending aortic aneurysm repair 12 (15.8%) 11 (15.9%) 1.0
Aortic arch surgery 10 (13.2%) 10 (14.5%) 1.0
Abdominal aortic aneurysm repair 19 (25.0%) 8 (11.6%) .05
Predicted rate of paraplegia or paraparesis11 26 (34.2%) 24 (34.8%) 1.0
Continuous variables are presented as mean ± standard deviation.
*Chronic obstructive pulmonary disease was defined as requirement of pharmacologic therapy for treatment of chronic pulmonary compromise or forced
expiratory volume in 1 second of less than 75% of predicted value.
†Renal failure was defined as serum creatinine level of 3.0 mg/dL or more or need for hemodialysis.
‡Acute presentation included acute pain, rupture, contained rupture, and complicated acute dissection.10,11
FEV1, Forced expiratory volume in 1 second; MDD, medial degenerative disease.
restricted to 1 to 3 because ambulation could not be
tested until clinically appropriate. For each patient with a
deficit, the worst (lowest) score was used to categorize the
deficit as paraplegia (scores of 1 or 2) or paraparesis (3 or
4). All deficits were scored and categorized, regardless of
the degree or rate of any subsequent improvement.
Neurologic deficits present on awakening from anesthesia
were classified as immediate; deficits that occurred after
previously normal postoperative examination were classi-
fied as delayed. Unilateral lower extremity deficits were
attributed to spinal cord injury unless an associated deficit
involving the ipsilateral upper extremity—indicating a
stroke—was present.
Statistical analysis. After performance of an inten-
tion-to-treat analysis that included all randomized
patients, an efficacy analysis was performed. In this sec-
ondary analysis, any patient in whom LHB could not be
used was withdrawn to eliminate LHB as a variable.
Patients who did not undergo extent I or II repair because
of intraoperative findings were also excluded from the sec-
ondary analysis. The efficacy analysis, therefore, focused
solely on extent I and II repairs completed with LHB.
The statistical analysis was performed with the SAS
system for Windows (release 6.10; SAS Institute, Inc,
Cary, NC). Comparisons between the CSFD and control
patient groups were performed with the Fisher exact test
for categoric variables and the Student t test for continu-
ous variables. Associations between aortic clamp time,
CSFD, and the risk of paraplegia were further analyzed
with logistic regression curves. P values of less than .05
were considered statistically significant. Continuous values
were reported as mean ± standard deviation. 
RESULTS
Intention-to-treat analysis. Paraplegia or paraparesis
occurred in nine of 74 patients (12.2%) in the control
group versus two of 82 patients (2.7%) who underwent
CSFD (P = .03). The overall operative mortality rate23 was
7.1% (11 of 156), which included six deaths within 30
days (range, 5 to 24 days) and five subsequent deaths in
hospital (range, 33 to 140 days). All patients survived long
enough to undergo neurologic assessment. Thirty-day
mortality rates for patients in the control and CSFD
groups were 2.7% (2/74) and 4.9% (4/82), respectively
(P = .68). In-hospital mortality rates were also similar in
both groups: 6.8% (5/74) for patients in the control
group and 7.3% (6/82) for patients in the CSFD group 
(P = 1.0).
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Table II. Comparison of operative and postoperative variables for patients who underwent thoracoabdominal aortic
aneurysm repair with and without cerebrospinal fluid drainage
Variable CSFD (n = 76) Control (n = 69) P value
Left heart bypass time (minutes) 21.0 ± 6.9 22.0 ± 6.9 .35
Cross-clamp and ischemic times* (minutes)
Total aortic clamp time 53.8 ± 15.3 55.1 ± 16.2 .62
Total unprotected aortic clamp time 34.6 ± 13.9 34.8 ± 13.6 .91
Intercostal ischemic time 46.3 ± 12.2 47.4 ± 12.0 .56
Unprotected intercostal ischemic time 26.9 ± 10.6 27.3 ± 8.5 .82
Visceral ischemic time 48.7 ± 14.0 48.8 ± 12.7 .95
Unprotected visceral ischemic time 23.1 ± 13.7 24.3 ± 11.4 .57
Body temperature before cross-clamping (°C) 34.9 ± 5.0 34.4 ± 1.1 .59
Body temperature after declamping (°C) 32.7 ± 0.8 32.9 ± 0.9 .29
Total reattached intercostal arteries (pairs) 2.3 ± 0.9 2.3 ± 1.0 .91
Patients without intercostal reattachment 2 (2.6%) 4 (5.8%) .42
Patients with reattached intercostal arteries
T6 1 (1.3%) 0 1.0
T7 1 (1.3%) 2 (2.9%) .60
T8 14 (18.4%) 11 (15.9%) .83
T9 32 (42.1%) 33 (47.8%) .51
T10 55 (72.4%) 50 (72.5%) 1.0
T11 43 (56.6%) 38 (55.1%) .87
T12 27 (35.5%) 18 (26.1%) .28
Lumbar 0 2 (2.9%) .22
Intercostal endarterectomy and reattachment 2 (2.6%) 1 (1.4%) 1.0
Intercostal artery bypass from aortic graft 1 (1.3%) 0 1.0
Bifurcated graft for iliac revascularization 5 (6.6%) 2 (2.9%) .45
Intraoperative hypotension (MAP <60 mm Hg) 13 (17.1%) 11 (15.9%) 1.0
Postoperative hypotension (MAP <70 mm Hg) 31 (40.8%) 19 (27.5%) .12
Transfusion (units)
Cell saver 18.1 ± 13.7 16.8 ± 10.6 .55
Packed red blood cells 3.1 ± 1.9 3.2 ± 2.0 .77
Platelets 6.6 ± 9.0 5.2 ± 7.9 .33
Fresh frozen plasma 7.1 ± 9.4 6.9 ± 8.9 .86
Cryoprecipitate 0.9 ± 5.2 1.2 ± 5.9 .74
*Unprotected clamp and ischemic times were calculated with subtraction of left heart bypass time from clamp or ischemic time in question. 
CSFD, Cerebrospinal fluid drainage; T, thoracic vertebrae; MAP, mean arterial pressure.
Efficacy analysis. For sole focus on extent I and II
repairs completed with LHB, which left CSFD as the only
treatment variable, the secondary efficacy analysis was per-
formed after the elimination of the 11 patients who met
intraoperative exclusion criteria (Fig 1). Five patients in each
group were withdrawn because of an intraoperative decision
not to use LHB; this was generally because of an inability to
safely clamp the mid-descending thoracic aorta. In two
patients in the CSFD group, extent II repairs were planned,
but lesser resections were performed on the basis of intra-
operative findings; both patients were withdrawn. All 11
patients who were withdrawn survived without deficits.
Ultimately, 69 patients in the control group and 76 patients
in the CSFD group were entered into the efficacy analysis
detailed subsequently.
Comparison of preoperative and intraoperative
factors. There were no significant differences in preoper-
ative characteristics between the two groups (Table I).
There were trends toward more patients with severe pain
and previous abdominal aortic aneurysm repair in the
CSFD group. More importantly, the distributions of
TAAA extents, aortic dissection, and acute presentation—
well-established risk factors for spinal cord injury after
TAAA repair—were similar in the two groups. Acher et
al’s11 predictive formula for paraplegia and paraparesis was
applied to each group; this model showed that the two
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groups were at similar overall risk for neurologic deficits.
Similarly, there were no significant differences between
intraoperative variables, including clamp and ischemic
times, body temperatures, and reattachment of intercostal
arteries (Table II).
Cerebrospinal fluid drainage. In the CSFD group,
64.1 ± 42.9 mL of CSF (range, 10 to 250 mL) were
drained during surgery and 260.9 ± 190.5 mL of CSF
(range, 40 to 864 mL) were drained during the postoper-
ative period. In two patients, the CSFD catheter became
occluded during surgery. One CSFD catheter became dis-
lodged while the patient was transported to the intensive
care unit. These three catheters were not replaced. There
were no other complications (eg, CSF leak or catheter
infection) related to the CSFD protocol. In all patients
with functioning spinal catheters, CSF pressure was main-
tained at 10 mm Hg or less.
Neurologic deficit. The characteristics of each patient
with a deficit are detailed in Table III. Eight of nine
patients in the control group who had deficits had CSFD
catheters placed after the deficit developed. Having
reached the study endpoint (paraplegia or paraparesis), the
patients remained in the control group for all analyses.
Rapid neurologic improvement did not occur after
catheter insertion in any of these eight patients. All three
patients with malfunctioning or dislodged CSFD catheters
Table III. Characteristics of patients in whom paraplegia or paraparesis developed after thoracoabdominal aortic
aneurysm repair
Extent Timing Degree Initial 
of of of postoperative Postoperative
Group repair injury injury score CSFD Final score Outcome
Control II Immediate Paraplegia 1 Yes 1 Death
Control II* Immediate Paraplegia 1 Yes 1 No improvement
Control II Immediate Paraplegia 2 Yes 4 Improved
Control II Immediate Paraplegia 2 Yes 4 Improved
Control I Immediate Paraplegia 2 Yes L, 2; R, 4 Death
Control II Immediate Paraplegia 1 Yes 3 Death
Control II Immediate Paraparesis 3 Yes 3 Death
Control II Delayed Paraparesis 3 No 4 Improved
Control II* Delayed Paraplegia 2 Yes 2 No improvement
CSFD I Immediate Paraparesis 3 Yes 4 Death
CSFD I Delayed Paraplegia 1 Yes 1 No improvement
*Aortic clamp placed proximal to left subclavian artery.
CSFD, Cerebrospinal fluid drainage; L, left; R, right.
Table IV. Postoperative lower extremity neurologic deficits after repair of extensive thoracoabdominal aortic aneurysms
Neurologic CSFD Control Risk reduction
injury (n = 76) (n = 69) P value Absolute Relative
All lower extremity neurologic deficits 2 (2.6%) 9 (13.0%) .03 10.4% 80%
Immediate neurologic deficits 1 (1.3%) 7 (10.1%) .03 8.8% 87.1%
Paraplegia 0 6 (8.7%) .01 8.7% 100%
Paraparesis 1 (1.3%) 1 (1.4%) 1.0
Delayed neurologic deficits 1 (1.3%) 2 (2.9%) .60
Paraplegia 1 (1.3%) 1 (1.4%) 1.0
Paraparesis 0 1 (1.4%) .48
CSFD, Cerebrospinal fluid drainage.
survived without deficits. On the basis of the intention-to-
treat principle, these three patients remained in the CSFD
group for all analyses.
Neurologic injuries developed in two patients in the
CSFD group (2.6%) and in nine patients in the control group
(13.0%; P = .026). This corresponds to an 80% reduction in
the relative risk of paraplegia or paraparesis. Logistic regres-
sion curves show that the longer the ischemic times were, the
greater the benefit afforded with CSFD (Fig 2). CSFD
reduced immediate deficits, particularly paraplegia (Table IV).
One patient in the CSFD group (1.3%) had immediate mod-
erate paraparesis involving the left lower extremity; this
patient’s condition improved substantially within 2 weeks,
and the patient was ultimately able to walk with assistance. In
contrast, seven patients in the control group had immediate
neurologic deficits (10.1%; P = .03). Delayed neurologic
deficits were infrequent in both groups. The single delayed
deficit that occurred in a patient in the CSFD group mani-
fested immediately after a period of atrial fibrillation and
hypotension on postoperative day 1; this resulted in perma-
nent paraplegia.
The volume of CSF drained during surgery was not dif-
ferent between patients with and without neurologic injury
(64.1 ± 5.2 mL versus 62.5 ± 12.5 mL, respectively; P = .96).
The average duration of spinal catheter drainage was 77 ± 5
hours and 42.7 ± 1.8 hours for patients with and without neu-
rologic injury, respectively (P = .003). The extended period of
CSFD in the two patients in whom deficits developed resulted
in an increase in the amount of postoperative drainage (533.3
± 120 mL) compared with the amount drained from the
patients without neurologic injury (250.0 ± 21.5 mL; P = .01).
In nine of 11 patients with deficits (81.8%), the aortic
clamp was placed distal to the left subclavian artery. The clamp
was initially positioned proximal to the left subclavian artery
in two patients with deficits; both were in the control group
(Table III).
With the strong association between immediate paraplegia
and surgery without CSFD, a subgroup analysis regarding risk
factors for immediate paraplegia was performed (Table V). In
addition to surgery without CSFD, only two factors were asso-
ciated with immediate paraplegia: total unprotected aortic
clamp time (P = .03) and total aortic clamp time (P = .04).
Mortality rate. The overall operative mortality rate for
the efficacy analysis group was 7.6% (11 patients).23 This rate
consisted of six 30-day deaths (4.1%) and five in-hospital
deaths beyond 30 days. Thirty-day mortality rates were 5.3%
(four patients) and 2.9% (two patients) for CSFD and control
groups, respectively (P = .68). The operative mortality rate for
patients with deficits was 45.5% (5/11) in contrast to 4.5%
(6/134) for those without deficits (P = .0003).
DISCUSSION
The rationale for CSFD during TAAA repair is on the
basis of experimental data that show: 1, CSF pressure
increases during aortic clamping; and 2, reduction of CSF
pressure improves spinal perfusion pressure.24-28 Although
the report by Murray et al5 did not show any improvement
with CSFD treatment, most retrospective comparative clin-
ical reports15-17,29 have suggested that CSFD may be ben-
eficial. However, limitations in these reports, including
heterogeneity of study groups, use of historic controls, and
use of concomitant protective methods, make it difficult to
specifically evaluate the contribution of CSFD to improve-
ments in outcome.
In 1990, Crawford et al18 reported a randomized trial
that evaluated intraoperative CSFD during extent I and II
TAAA repairs. Of 98 total patients, 46 (46.9%) underwent
CSFD and 52 (53.1%) served as controls. Overall, 31
patients (31.6%) had paraplegia or paraparesis develop: 14
in the CSFD group (30.4%) and 17 in the control group
(32.7%; P = .8). Factors associated with neurologic deficits
included advanced age, extent II repair, increasing cross-
clamp time, and postoperative hypotension. Although
CSFD did not reduce deficits, the Institutional Review
Board only allowed 50 mL of drainage during this study,
which may have precluded any potential benefit.
In 1998, Svensson et al13 reported a randomized trial
with 33 patients in two centers. All patients had extent I or
II TAAAs. Seventeen patients underwent CSFD and
intrathecal papaverine hydrochloride treatment, and 16
patients served as controls. Other adjuncts, including LHB
and active cooling, were used inconsistently in the two
groups. There was a trend toward higher preoperative risk
in the control group. For example, the control group had
more emergent and urgent cases (7/16; 44%) than did the
CSFD group (4/17; 25%). This difference did not reach
statistical significance because of the sample size. Similarly,
the control group showed a strong tendency toward more
severe symptoms at presentation. Constant pain, life-threat-
ening acute dissection, or shock were present in 56% of
patients in the control group versus only 35% in the CSFD
group. Neurologic injuries occurred in two patients in the
CSFD/papaverine hydrochloride treatment group (11.0%)
and in seven patients in the control group (43.8%; P = .06,
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Table V. Subgroup analysis of variables examined for association with immediate postoperative paraplegia
Without immediate With immediate
postoperative postoperative
Variable paraplegia (n = 139) paraplegia (n = 6) P value
Surgery without cerebrospinal fluid drainage 63 (45.3%) 6 (100.0%) .01
Total unprotected aortic clamp time* (minutes) 34.2 ± 13.5 48.8 ± 12.8 .03
Total aortic clamp time (minutes) 53.8 ± 15.6 67.3 ± 11.3 .04
*Total unprotected aortic clamp time was calculated with subtraction of left heart bypass time from total aortic clamp time.
with Fisher exact test). Although the authors concluded
that the combined use of CSFD and intrathecal papaverine
hydrochloride was beneficial, the impact of CSFD alone is
difficult to interpret.
This randomized trial focused solely on CSFD and its
impact on neurologic deficits. The reduction in deficits was
significant in both the intent-to-treat and efficacy analyses.
In the latter, the CSFD and control groups were well
matched with respect to established risk factors for paraple-
gia. All other adjuncts were used consistently in both
groups, and there were no limitations in the amount of
CSF that could be drained in obtaining target CSF pres-
sures of 10 mm Hg or less.
We recently reported paraplegia rates of 3.9% for
extent I repairs and 8.2% for extent II repairs.3 The appar-
ent increase in deficits in the control group (13%) relative
to our previous data is difficult to explain but may be
related to a more intensive focus on neurologic status dur-
ing this prospective study. Nevertheless, the paraplegia
rates in the control and CSFD groups are substantially
lower than those reported in the other two randomized
trials13,18 and compare favorably with previous compara-
tive retrospective studies (range, 6% to 22% in controls
and 0% to 9% with CSFD), many of which include less
extensive aneurysm repairs.5,11,16,17
Recent reports have described isolated cases in which
patients with delayed paraplegia after TAAA repair under-
went successful treatment with CSFD.30-32 In a retrospec-
tive review, Safi et al33 reported neurologic improvement
after initiation of CSFD in eight patients with delayed
deficits. During our study, CSFD was initiated in eight of
nine control patients (89%) who had postoperative deficits.
Neurologic function did improve in four of these patients
(50%), but improvements occurred gradually, in contrast to
the immediate resolution reported by other investigators.
Improvement also occurred in the one patient who did not
have a CSFD catheter placed after development of a deficit
(Table III). Furthermore, all patients in whom deficits
developed were immediately treated with a multimodality
approach that included judiciously raising blood pressure,
optimizing oxygen delivery, and administering intravenous
steroids, mannitol, and naloxone hydrochloride. This
immediate initiation of multimodality treatment makes it
impossible to attribute subsequent recovery to any individ-
ual maneuver. Although we have not personally encoun-
tered immediate restoration of neurologic function after
initiation of CSFD in patients with delayed onset paraple-
gia, the devastating nature of spinal cord injury combined
with the potential for benefit suggest that it is appropriate
to insert a CSFD catheter in these patients.
Several limitations of this study require discussion.
Blinding the surgical team to treatment group was not fea-
sible because CSFD requires active management during
and after operation. A blinded examiner to perform post-
operative neurologic assessment, however, would have
improved this aspect of study design.
Insertion of a CSFD catheter in patients in the control
group (without draining fluid) may have provided a more
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pure control group. Monitoring CSF pressure in both
CSFD and control patients would have provided interest-
ing comparison data and may have further enhanced our
understanding of relationships between aortic clamping,
LHB, CSFD, and CSF pressures. However, because this
was not the focus of our study, CSF pressure data were not
collected prospectively at predetermined time points in the
experimental group and catheters were not placed in
patients in the control group. Although rare, complications
related to these catheters can be devastating, and the expo-
sure of patients to risk without potential benefit was not
justifiable.
The scoring system used in this study was also used
during the previous randomized trial in our institution.18
Scoring early postoperative lower extremity function is
often difficult, especially in patients with cardiac, pul-
monary, and other neurologic complications. The ability
to stand and walk cannot be assessed until patients are
hemodynamically stable, are extubated, and have a satis-
factory mental status. The use of ambulation as a measure,
however, is important when quantifying a patient’s degree
of disability. The scoring system recently used by Svensson
et al13 focuses more on straight-leg raises and seems well
suited for use throughout the postoperative course.
Although this trial clearly shows the benefit of CSFD
during the repair of extent I and II TAAAs, the results
cannot be extrapolated to the repair of less extensive
aneurysms. There is currently no clinical evidence that
show that CSFD prevents deficits during the repair of
descending thoracic and extent III or IV TAAAs.
Finally, patients who underwent CSFD did not have
improved survival rates. The study confirmed the estab-
lished association between paraplegia and death1; the mor-
tality rate was 10 times higher in patients with deficits than
in those without. A substantial reduction in paraplegia
should ultimately also reduce mortality rates. The demon-
stration of whether CSFD significantly reduces early or
late mortality rates requires a larger study.
Fig 2. Logistic regression curves show reduction in risk of para-
plegia or paraparesis associated with CSFD.
Ischemic spinal cord injuries are the result of complex
interactions between several factors: perfusion and oxygen
delivery, local metabolic rate and oxygen demand, reper-
fusion injury, and failure to maintain microcirculatory
flow.34 Therefore, although CSFD provides spinal cord
protection, the risk of neurologic deficit cannot be por-
trayed as a simple balance between CSF pressure and dis-
tal aortic pressure. A more appropriate model—the
ischemic time versus deficit risk curve introduced by
Svensson and Loop35 in 1988—has been used to illustrate
the efficacy of various adjuncts. Techniques that reduce
the risk of paraplegia shift the curve to the right (Fig 2),
which corresponds to a reduction in risk for a given
ischemic time. Conversely, factors that contribute to spinal
cord injury shift the curve to the left. In addition to use of
this model to show the benefit of CSFD, we have used the
curve to illustrate the protective effect of LHB.2 In the
recent report by Svensson et al,13 the relative effects of
active systemic cooling, CSFD, and intrathecal papaverine
hydrochloride treatment were illustrated as progressive
rightward shifts of this curve. As the intricacies of ischemic
spinal cord injury continue to be elucidated, this flexible
conceptual model can be adapted to show the impact of
newly recognized risk factors and preventive strategies.
We thank Peter J. Oberwalder, MD, and José Pagan,
MD, for their logistical and technical assistance during the
study, and Charles C. Miller III, PhD, for his assistance
with statistical analysis, especially the logistic regression
curves.
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